Related references
Note: Only part of the references are listed.Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease
Alan Whone et al.
BRAIN (2019)
Prevalence of Parkinson's disease across North America
C. Marras et al.
NPJ PARKINSONS DISEASE (2018)
AAV viral vector delivery to the brain by shape-conforming MR-guided infusions
Krystof S. Bankiewicz et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
C. Warren Olanow et al.
ANNALS OF NEUROLOGY (2015)
Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas
Prashant Chittiboina et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2014)
Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
Yohei Mineharu et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
Adrian P. Kells et al.
NEUROBIOLOGY OF DISEASE (2012)
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
R. Mark Richardson et al.
MOLECULAR THERAPY (2011)
Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
Dali Yin et al.
NEUROIMAGE (2011)
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Adrian P. Kells et al.
JOURNAL OF NEUROSCIENCE (2010)
Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain
Piotr Hadaczek et al.
NEUROPHARMACOLOGY (2010)
Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
Louisa C. Johnston et al.
HUMAN GENE THERAPY (2009)
Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
Xiaomin Su et al.
HUMAN GENE THERAPY (2009)
Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
Pekka Jokinen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
The GDNF family: Signalling, biological functions and therapeutic value
MS Airaksinen et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
A Björklund et al.
BRAIN RESEARCH (2000)
Long-term rAAV-mediated gene transfer of GDNF in the rat parkinson's model:: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
D Kirik et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
